Your browser doesn't support javascript.
loading
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma.
Kaufman, Jonathan L; Gasparetto, Cristina; Schjesvold, Fredrik H; Moreau, Philippe; Touzeau, Cyrille; Facon, Thierry; Boise, Lawrence H; Jiang, Yanwen; Yang, Xiaoqing; Dunbar, Fengjiao; Vishwamitra, Deeksha; Unger, Stefanie; Macartney, Tammy; Pesko, John; Yu, Yao; Salem, Ahmed Hamed; Ross, Jeremy A; Hong, Wan-Jen; Maciag, Paulo C; Pauff, James M; Kumar, Shaji.
Afiliación
  • Kaufman JL; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
  • Gasparetto C; Duke University, Hematologic Malignancies & Cellular Therapy, Durham, North Carolina, USA.
  • Schjesvold FH; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway and K.G. Jebsen Center for B-cell malignancies, University of Oslo, Oslo, Norway.
  • Moreau P; University Hospital, Nantes, France CRCINA, INSERM, Centre National de la Recherche Scientifique, University of Angers, University of Nantes, Nantes, France.
  • Touzeau C; University Hospital, Nantes, France CRCINA, INSERM, Centre National de la Recherche Scientifique, University of Angers, University of Nantes, Nantes, France.
  • Facon T; Centre Hospitalier Regional Universitaire Lille, Hospital Huriez, Lille, France.
  • Boise LH; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
  • Jiang Y; Genentech Inc., South San Francisco, California, USA.
  • Yang X; AbbVie Inc, North Chicago, Illinois, USA.
  • Dunbar F; AbbVie Inc, North Chicago, Illinois, USA.
  • Vishwamitra D; AbbVie Inc, North Chicago, Illinois, USA.
  • Unger S; AbbVie Inc, North Chicago, Illinois, USA.
  • Macartney T; AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany.
  • Pesko J; AbbVie Inc, North Chicago, Illinois, USA.
  • Yu Y; AbbVie Inc, North Chicago, Illinois, USA.
  • Salem AH; AbbVie Inc, North Chicago, Illinois, USA.
  • Ross JA; AbbVie Inc, North Chicago, Illinois, USA.
  • Hong WJ; Genentech Inc., South San Francisco, California, USA.
  • Maciag PC; AbbVie Inc, North Chicago, Illinois, USA.
  • Pauff JM; AbbVie Inc, North Chicago, Illinois, USA.
  • Kumar S; Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 96(4): 418-427, 2021 04 01.
Article en En | MEDLINE | ID: mdl-33368455
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteínas Proto-Oncogénicas c-bcl-2 / Mieloma Múltiple / Proteínas de Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteínas Proto-Oncogénicas c-bcl-2 / Mieloma Múltiple / Proteínas de Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos